एपीए उद्धरण

Blum, K. A., Polley, M., Jung, S., Dockter, T. J., Anderson, S., Hsi, E. D., . . . Bartlett, N. L. (2019). Randomized Trial of Ofatumumab and Bendamustine versus Ofatumumab, Bendamustine and Bortezomib in previously untreated patients with highrisk follicular lymphoma: CALGB 50904 (Alliance). Cancer.

शिकागो स्टाइल उद्धरण

Blum, Kristie A., et al. "Randomized Trial of Ofatumumab and Bendamustine Versus Ofatumumab, Bendamustine and Bortezomib in Previously Untreated Patients With Highrisk Follicular Lymphoma: CALGB 50904 (Alliance)." Cancer 2019.

एमएलए उद्धरण

Blum, Kristie A., et al. "Randomized Trial of Ofatumumab and Bendamustine Versus Ofatumumab, Bendamustine and Bortezomib in Previously Untreated Patients With Highrisk Follicular Lymphoma: CALGB 50904 (Alliance)." Cancer 2019.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.